Majken B Thomsen

PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats

D. Brooks, A. Landau, A. Schacht, 2020, Neurobiology of Disease.

A single dose of cocaine raises SV2A density in hippocampus of adolescent rats

A. Gjedde, A. Landau, R. Grassi‐Oliveira, 2023, Acta Neuropsychiatrica.

Autoradiographic characterization of [18F]PSMA‐1007 binding in rat brain

A. Landau, P. Cumming, D. Bender, 2023, Synapse.

Combined In Vivo Microdialysis and PET Studies to Validate [11C]Yohimbine Binding as a Marker of Noradrenaline Release

A. Alstrup, A. Landau, S. Jakobsen, 2023, Biomolecules.

Preclinical PET Studies of [11C]UCB-J Binding in Minipig Brain

D. Brooks, A. Alstrup, A. Landau, 2020, Molecular Imaging and Biology.

Neonatal domoic acid alters in vivo binding of [11C]yohimbine to α2-adrenoceptors in adult rat brain

A. Landau, S. Jakobsen, G. Wegener, 2016, Psychopharmacology.

α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease

A. Landau, S. H. Christiansen, D. Woldbye, 2021, Biomedicines.

In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET

D. Brooks, A. Landau, A. Schacht, 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Spontaneous Partial Recovery of Striatal Dopaminergic Uptake Despite Nigral Cell Loss in Asymptomatic MPTP-Lesioned Minipigs

D. Brooks, A. Alstrup, A. Landau, 2021 .

Selecting the Best Animal Model of Parkinson's Disease for Research Purpose: Insight from in vivo PET Imaging Studies.

D. Brooks, A. Landau, C. Real, 2023, Current neuropharmacology.